Stanley Plotkin | Academic Influence

Stanley Plotkin's AcademicInfluence.com Rankings

Stanley Plotkin

Philosophy

#2062

World Rank

#3599

Historical Rank

#771

USA Rank

Logic

#422

World Rank

#805

Historical Rank

#170

USA Rank

philosophy Degrees

Download Badge

Philosophy

Stanley Plotkin's Degrees

Doctorate Medicine New York University

Why Is Stanley Plotkin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.

(See a Problem?)

Stanley Plotkin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Correlates of Protection Induced by Vaccination (2010) (1303)
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line (1979) (1248)
Vaccines: correlates of vaccine-induced immunity. (2008) (679)
Evidence for antibody as a protective correlate for COVID-19 vaccines (2021) (603)
Vaccines: past, present and future (2005) (468)
Predictors of morbidity and mortality in neonates with herpes simplex virus infections (1991) (370)
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. (2004) (336)
History of vaccination (2014) (285)
Field Evaluation of a Human Anthrax Vaccine. (1962) (282)
Nomenclature for immune correlates of protection after vaccination. (2012) (265)
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. (1991) (258)
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. (1995) (254)
Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus Season (1988) (246)
Increased blood serotonin and platelets in early infantile autism. (1970) (245)
Accelerating Next-Generation Vaccine Development for Global Disease Prevention (2013) (243)
Immunologic correlates of protection induced by vaccination (2001) (242)
WHO International Standard for anti-SARS-CoV-2 immunoglobulin (2021) (241)
The development of vaccines: how the past led to the future (2011) (238)
The complexity and cost of vaccine manufacturing – An overview (2017) (227)
Complex correlates of protection after vaccination. (2013) (222)
Incidence of Lyme Borreliosis in the Würzburg Region of Germany (1999) (219)
Vaccines: the Fourth Century (2009) (216)
Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. (2007) (204)
TOWNE-VACCINE-INDUCED PREVENTION OF CYTOMEGALOVIRUS DISEASE AFTER RENAL TRANSPLANTS (1984) (201)
Varicella vaccine studies in healthy children and adults. (1986) (198)
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. (1991) (198)
Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. (1984) (197)
Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. (1991) (190)
The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants. (1996) (189)
Immunisation with canarypox virus expressing rabies glycoprotein (1992) (187)
Impact of Vaccines; Health, Economic and Social Perspectives (2020) (182)
New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. (2004) (182)
Candidate cytomegalovirus strain for human vaccination (1975) (181)
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. (1989) (164)
Human parvovirus B19 infection among hospital staff members after contact with infected patients. (1989) (159)
Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. (1976) (157)
Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. (1993) (157)
Life-threatening complications of varicella. (1981) (155)
Clinical Definitions of Pertussis: Summary of a Global Pertussis Initiative Roundtable Meeting, February 2011 (2012) (153)
Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study (2015) (153)
Growth Characteristics of Cytomegalovirus in Human Fibroblasts with Demonstration of Protein Synthesis Early in Viral Replication (1973) (153)
Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. (2012) (147)
MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS VACCINE IN SERONEGATIVE RENAL TRANSPLANT RECIPIENTS (1994) (147)
A rapid accurate procedure for the determination of serotonin in whole human blood. (1970) (146)
Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. (2000) (146)
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013 (2015) (143)
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. (2001) (141)
Correlates of Vaccine-Induced Immunity (2008) (136)
1 – A short history of vaccination (2013) (136)
Priorities for CMV vaccine development. (2013) (135)
An epidemic of inhalation anthrax, the first in the twentieth century. I. Clinical features. (1960) (135)
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000-2013. (2015) (134)
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. (1984) (132)
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne). (1999) (129)
Strategies to Decrease Pertussis Transmission to Infants (2015) (128)
Rubella vaccine. (1995) (128)
Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine. (1985) (125)
Outbreak of poliomyelitis‐like paralysis associated with enterovirus 71 (1989) (125)
Human cytomegalovirus stimulates host cell RNA synthesis (1975) (124)
The Global Meningococcal Initiative: recommendations for reducing the global burden of meningococcal disease. (2011) (115)
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. (1973) (114)
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. (1965) (113)
Inactivated poliovirus vaccine: past and present experience. (1996) (113)
Plotkin's Vaccines (2017) (112)
Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors (2004) (111)
THE IN VITRO GROWTH OF RUBELLA VIRUS IN HUMAN EMBRYO CELLS. (1965) (109)
Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells. (1969) (108)
Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. (2000) (106)
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines (2014) (106)
The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. (1985) (104)
Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system. (1996) (103)
A murine model for oral infection with a primate rotavirus (simian SA11) (1984) (102)
Immune response of infants and children to low-passage bovine rotavirus (strain WC3). (1986) (100)
Outbreak of cryptosporidiosis in a day-care center. (1986) (100)
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection (1992) (100)
Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. (1998) (99)
The pertussis problem. (2014) (99)
The history of rubella and rubella vaccination leading to elimination. (2006) (98)
Updates on immunologic correlates of vaccine-induced protection. (2019) (98)
Demonstration of immunoglobulin G receptors induced by human cytomegalovirus (1975) (97)
Viral infections in pediatric bone marrow transplant patients (1988) (97)
Vaccines, vaccination, and vaccinology. (2003) (97)
Potential Strategies to Reduce the Burden of Pertussis (2005) (96)
Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. (1992) (95)
Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. (1979) (94)
Complex immune correlates of protection in HIV‐1 vaccine efficacy trials (2017) (92)
Multiple bioassays to assess the toxicity of a sanitary landfill leachate (1984) (91)
Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. (1979) (88)
Integration pattern of hepatitis B virus DNA sequences in human hepatoma cell lines (1981) (86)
An epidemic of inhalation anthrax: the first in the twentieth century. II. Epidemiology. (1960) (86)
Vaccination against the human cytomegalovirus (2019) (84)
A new typhoid vaccine composed of the Vi capsular polysaccharide. (1995) (84)
Safety and immunogenicity of the Towne strain cytomegalovirus vaccine. (1998) (84)
Measles: Reassessment of the current immunization policy (1989) (84)
Desirability and feasibility of a vaccine against cytomegalovirus. (2013) (84)
Rapid detection of human cytomegalovirus in the urine of humans. (1985) (82)
Epidemiology of rotavirus electropherotypes determined by a simplified diagnostic technique with RNA analysis (1985) (82)
BACTEREMIA CAUSED BY PSEUDOMONAS SP. FOLLOWING THE USE OF MATERIALS STORED IN SOLUTIONS OF A CATIONIC SURFACE‐ACTIVE AGENT (1958) (82)
Haemophilus influenzae type B conjugate vaccine (1988) (82)
The acellular pertussis vaccine trials: an interpretation. (1997) (81)
Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection (2017) (80)
Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. (2002) (80)
27 – Poliovirus vaccine—inactivated (2013) (79)
Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. (1990) (79)
Establishing a Global Vaccine-Development Fund. (2015) (78)
Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains. (2005) (78)
Routine quantitative blood cultures in children with Haemophilus influenzae or Streptococcus pneumoniae bacteremia. (1985) (77)
Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers. (1990) (77)
Some recently recognized manifestations of the rubella syndrome (1965) (76)
Effects of L-dopa in autism (1971) (76)
History of vaccine development (2011) (74)
The safety and use of canarypox vectored vaccines. (1995) (74)
Varicella vaccination in Japan, South Korea, and Europe. (2008) (74)
Global incidence of serogroup B invasive meningococcal disease: a systematic review. (2015) (73)
Laboratory Studies on Rubella and the Rubella Syndrome (1963) (73)
The prime-boost concept applied to HIV preventive vaccines. (1997) (73)
Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. (1984) (73)
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid. (1986) (72)
Development of a cytomegalovirus vaccine: lessons from recent clinical trials (2001) (72)
Prevention of Diabetes in Rats by Bone Marrow Transplantation (1981) (72)
Plant-derived vaccines and antibodies: potential and limitations. (2005) (70)
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity (2013) (70)
Vaccination against cytomegalovirus, the changeling demon. (1999) (70)
Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. (1990) (69)
What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines. (2017) (68)
Preparation of poliovirus vaccines in a human fetal diploid cell strain. (1962) (68)
Human Fibroblasts Infected with Rubella Virus Produce a Growth Inhibitor (1967) (67)
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease (2022) (66)
Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus. (1965) (66)
Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group. (1991) (66)
Zoster in normal children after varicella vaccine. (1989) (66)
Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque reduction neutralization (1983) (65)
Nonproductive Infection of Guinea Pig Cells with Human Cytomegalovirus (1973) (65)
New Vaccines against Epidemic Infectious Diseases. (2017) (65)
Extraordinary diseases require extraordinary solutions (2020) (65)
Preclinical evaluation of an ALVAC (canarypox)--human cytomegalovirus glycoprotein B vaccine candidate. (1995) (64)
Mumps vaccine virus strains and aseptic meningitis. (2006) (64)
An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin. (2016) (64)
Herpetic paronychia--an occupational hazard of medical personnel. (1970) (63)
Safety and immunogenicity of a live recombinant canarypox virus expressing HIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection (1999) (62)
The New Pentavalent Rotavirus Vaccine Composed of Bovine (Strain WC3) -Human Rotavirus Reassortants (2006) (62)
A new attenuated rubella virus grown in human fibroblasts: evidence for reduced nasopharyngeal excretion. (1967) (62)
Canarypox virus-based vaccines: prime-boost strategies to induce cell-mediated and humoral immunity against HIV. (1998) (62)
Enhancement of Vaginal Infection in Mice by Herpes Simplex Virus Type II with Progesterone (1978) (61)
Vaccines for the prevention of human cytomegalovirus infection. (1990) (61)
Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience. (2012) (61)
Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. (2016) (61)
Towards a population-based threshold of protection for COVID-19 vaccines (2021) (61)
Immunological correlates of protection from HIV infection and disease (2006) (61)
Congenital rubella syndrome as a systemic infection. Studies of affected infants born in Philadelphia, U.S.A. (1965) (60)
The history of vaccination against cytomegalovirus (2015) (60)
Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine. (1997) (60)
Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines. (1996) (60)
The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010. (2011) (59)
Nosocomial meningitis of the newborn caused by a flavobacterium. (1966) (59)
A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience (2011) (59)
Specific cellular and humoral immunity after immunization with live Towne strain cytomegalovirus vaccine. (1981) (59)
Is there a formula for an effective CMV vaccine? (2002) (58)
Rubella eradication. (2001) (58)
Maturational changes in blood serotonin levels and platelet counts. (1971) (58)
Clinical trials in infants of orally administered attenuated poliomyelitis viruses. (1959) (58)
Further Serological Studies on the Rubella Syndrome (1964) (57)
Chemotherapy for Tuberculosis in Infants and Children (1992) (57)
Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization. (1999) (57)
Six Revolutions in Vaccinology (2005) (57)
Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). (1990) (56)
Correcting a public health fiasco: The need for a new vaccine against Lyme disease. (2011) (56)
A rapid microneutralization assay for cytomegalovirus. (1986) (55)
Possible options for new pertussis vaccines. (2014) (54)
Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy. (1990) (54)
Immune responses to isolated human cytomegalovirus envelope proteins (1986) (54)
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them. (2020) (54)
CEPI: Driving Progress Toward Epidemic Preparedness and Response (2019) (52)
Involvement of a p53-dependent pathway in rubella virus-induced apoptosis. (1999) (52)
Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. (1994) (51)
The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides. (1983) (51)
The Global Pertussis Initiative: Meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010 (2011) (51)
Elevated daytime melatonin concentrations in autism: A pilot study (1993) (50)
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections (2018) (50)
Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. (1966) (50)
Human cell culture rabies vaccine. Antibody response in man. (1973) (49)
Acute monoarticular arthritis caused by herpes simplex virus and cytomegalovirus. (1980) (49)
Moving ahead an HIV vaccine: Use both arms to beat HIV (2011) (49)
Minimal infective dose of attenuated poliovirus for man. (1967) (49)
The Status of Vaccine Development Against the Human Cytomegalovirus. (2020) (49)
Successful islet transplantation in spontaneous diabetes. (1979) (49)
Assessing the Safety of Adjuvanted Vaccines (2011) (48)
Human cytomegalovirus infection of WI-38 cells stimulates mitochondrial DNA synthesis (1976) (48)
Combination measles, mumps, rubella and varicella vaccine. (1986) (48)
Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules. (2003) (48)
Live attenuated varicella vaccine: immunization of healthy children with the OKA strain. (1982) (48)
A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus-Seronegative Men. (2016) (47)
Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies (2019) (46)
An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies. (1990) (46)
Vaccination against the major infectious diseases (1999) (46)
Immunogenicity of a two-component (PT&FHA) acellular pertussis vaccine in various combinations (2008) (45)
High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity. (1991) (45)
Development and clinical trials of the new human rabies vaccine of tissue culture (human diploid cell) origin. (1978) (45)
Candidal osteomyelitis and arthritis in a neonate. (1972) (44)
Vaccines for epidemic infections and the role of CEPI (2017) (44)
Attempts to recover varicella virus from ganglia (1977) (44)
Congenital rubella syndrome in late infancy. (1967) (43)
Acyclovir treatment of herpes zoster infections. Use in children undergoing bone marrow transplantation. (1982) (43)
Vaccination of pediatric nurses with live attenuated cytomegalovirus. (1982) (43)
Vaccination against the major infectious diseases. (1999) (42)
Induction of DNA Polymerase in WI-38 and guinea pig cells infected with human cytomegalovirus (HCMV). (1976) (41)
Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants. (1990) (40)
An epidemic of inhalation anthrax, the first in the twentieth century: I. Clinical features. 1960. (2002) (39)
Correlates of protection for enteric vaccines. (2017) (39)
The Global Pertussis Initiative: Process Overview (2005) (39)
Toward a Human Vaccines Project (2014) (39)
Rotavirus serotype-specific neutralizing activity in human milk. (1988) (39)
Precipitin responses to rubella vaccine RA 27-3. (1971) (38)
Vancomycin pharmacokinetics in infants: relationships to indices of maturation. (1986) (38)
Cytomegalovirus infection of human teratocarcinoma cells in culture. (1985) (38)
Rabies vaccine prepared in human cell cultures: progress and perspectives. (1980) (37)
Protective Immunity and New Vaccines for Lyme Disease (2019) (37)
Strains of human viruses (1972) (37)
Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens (1980) (37)
Treatment of congenital cytomegalic inclusion disease with antiviral agents. (1969) (36)
Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study (1991) (36)
In vitro and in vivo responses of cytomegalovirus to acyclovir. (1982) (36)
Mass Vaccination : Global Aspects - Progress and Obstacles (2006) (36)
Acquisition of cytomegalovirus infection among female employees at a pediatric hospital (1984) (36)
A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes (2010) (36)
Use of predictive markers of HIV disease progression in vaccine trials. (2009) (35)
Immunization schedules for the new human diploid cell vaccine against rabies. (1976) (35)
Children hospitalized with influenza B infection (1987) (35)
Diverse serologic response to rotavirus infection of infants in a single epidemic. (1985) (35)
Lessons learned concerning vaccine safety. (2001) (35)
A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood. (1968) (34)
Waning Immunity and Microbial Vaccines—Workshop of the National Institute of Allergy and Infectious Diseases (2017) (34)
Oral polio immunization of the newborn infant; a possible method for overcoming interference by ingested antibodies. (1968) (34)
Optimization of DNA immunization against human cytomegalovirus. (2001) (33)
Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative. (2017) (33)
Growth of Rubella Virus in BHK21 Cells. I. Production, Assay, and Adaptation of Virus.∗ (1967) (33)
Mechanisms and pathways of congenital infections. (1988) (33)
A Type 3 Attenuated Poliovirus Genetically Stable after Human Intestinal Passage.∗ (1961) (33)
Considering Mandatory Vaccination of Children for COVID-19 (2021) (33)
Intratypic serodifferentiation of polioviruses (1961) (33)
Cells infected with human cytomegalovirus release a factor(s) that stimulates cell DNA synthesis. (1984) (33)
Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants (1997) (32)
VACCINES, 3rd Edition (1999) (32)
Cryptosporidiosis in a day-care center. (1984) (32)
Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts (1989) (32)
Humoral immune response to cytomegalovirus Towne vaccine strain and to Toledo low-passage strain. (1989) (32)
Hypogammaglobulinemia in an infant with congenital rubella syndrome; failure of 1-adamantanamine to stop irus excretion. (1966) (32)
A call to action for the new decade of vaccines (2011) (31)
Differentiation of human embryonal carcinoma cells induces human immunodeficiency virus permissiveness which is stimulated by human cytomegalovirus coinfection (1991) (31)
Gastroenteritis Caused By Human Rotaviruses (Serotype Three) In A Suckling Mouse Model* (1987) (31)
Treatment of bacterial meningitis (1988) (31)
Serologic testing for anthrax antibodies in workers in a goat hair processing mill. (1960) (30)
HIV vaccine development at the turn of the 21st century. (2012) (30)
American Academy of Pediatrics Task Force on Pediatric AIDS: Pediatric guidelines for infection control of human immunodeficiency virus (acquired immunodeficiency virus) in hospitals, medical offices, schools, and other settings. (1988) (30)
Summary of a workshop on new and useful methods in rapid viral diagnosis. (1980) (30)
Stimulation of Macromolecular Synethesis in Guinea Pig Cells by Human CMV 1 (1975) (30)
Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine. (1984) (30)
Inactivated polio vaccine for the United States: a missed vaccination opportunity (1995) (30)
Supernatant virus release as a differentiating marker between low passage and vaccine strains of human cytomegalovirus. (1983) (29)
Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB. (1993) (29)
Virus‐inhibiting surgical glove to reduce the risk of infection by enveloped viruses (2003) (29)
The eradication of rubella. (1999) (29)
The Characterization of IgG Receptor Induced by Human Cytomegalovirus 1 (1977) (29)
Parvovirus, Erythema Infectiosum, and Pregnancy (1990) (28)
Education of children with human immunodeficiency virus infection. (1991) (28)
Why certain vaccines have been delayed or not developed at all. (2005) (27)
Clinical development of a new inactivated hepatitis a vaccine (1996) (27)
Aims, Scope and Findings of the Global Pertussis Initiative (2005) (27)
Chromosome Studies of Human Cells Infected in utero and in vitro With Rubella Virus.∗ (1966) (27)
Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy (2017) (27)
Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries. (2003) (27)
Vaccination in the 21st century. (1993) (27)
Need for a New Lyme Disease Vaccine. (2016) (27)
Variations in the responses of infants to living attenuated poliovirus vaccines. (1961) (26)
Vaccination against cytomegalovirus. (2001) (26)
Cytomegalovirus vaccine virus (Towne strain) does not induce latency. (1985) (26)
Cost of varicella in France: a study in day care centers. (1998) (26)
Pertussis: Biology, epidemiology and prevention. (2016) (26)
Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination. (1960) (26)
Congenital rubella cataracts. Surgical results and virus recovery from intraocular tissue. (1967) (25)
Markers of Rubella Virus Strains in RK13 Cell Culture (1969) (25)
Synthesis of Virus and Macromolecules by Rubella-Infected Cells (1966) (25)
Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update. (2018) (25)
T-lymphocyte subsets and proliferative responses following immunization with cytomegalovirus vaccine. (1983) (25)
Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines. (2006) (25)
Vancomycin dosage in pediatrics reconsidered. (1984) (25)
Intranasally administered rubella vaccine. (1968) (24)
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. (1999) (24)
Immunity and Virus Infection (1960) (24)
Disposition of chloramphenicol in low birth weight infants. (1980) (24)
Outbreak of fatal adenoviral type 7a respiratory disease in a children's long-term care inpatient facility. (1986) (24)
Summary of a workshop on new and useful methods in viral diagnosis. (1978) (24)
Isolation from Animals of Human Strains of Staphylococci during an Epidemic in a Veterinary School (1960) (23)
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines. (2022) (23)
Increasing Complexity of Vaccine Development. (2015) (23)
History of RA27/3 rubella vaccine. (1985) (23)
Failures of protection by measles vaccine. (1973) (23)
VIROLOGIC ASSISTANCE IN THE MANAGEMENT OF GERMAN MEASLES IN PREGNANCY. (1964) (23)
Immunisation of schoolchildren with rubella (RA27-3) vaccine. Intranasal and subcutaneous administration. (1970) (23)
Human diploid cell strains (HDCS) viral vaccines. (1998) (23)
POSTSYNAPTIC ADRENERGIC‐CYCLIC AMP CONTROL OF THE SEROTONIN CONTENT OF CULTURED RAT PINEAL GLANDS (1973) (23)
Natural vs Vaccine-Acquired Immunity to Cytomegalovirus—Reply (2003) (22)
Enzootic sendai infection in laboratory hamsters. (1969) (22)
Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotaviruses. (1986) (22)
Resistance of seropositive volunteers to subcutaneous challenge with low-passage human cytomegalovirus. (1985) (22)
Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries (2011) (22)
Ampicillin-Resistant, β-Lactamase-Negative Haemophilus influenzae Type b (1982) (22)
HCMV Envelope Antigens Induce Both Humoral and Cellular Immunity in Guinea Pigs 1 (1984) (21)
Microbial evolution (Communication arising): Antitoxin vaccines and pathogen virulence (2002) (21)
Severe Epstein-Barr virus pulmonary involvement. (1981) (21)
Direct copper(I) iodide dimethyl sulfide catalyzed conjugate addition of alkenyl groups from vinylzirconocene reagents. (2004) (21)
Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children. (1992) (21)
Routes of fetal infection and mechanisms of fetal damage. (1975) (21)
Acellular vaccine efficacy trials. (1997) (21)
Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994. (1997) (21)
Live attenuated varicella vaccine: the KMcC strain in healthy children. (1983) (21)
CHAT oral polio vaccine was not the source of human immunodeficiency virus type 1 group M for humans. (2001) (20)
Detection of antibody to cytomegalovirus early antigen in vaccinated, normal volunteers and renal transplant candidates. (1982) (20)
Vaccination of Families Against Poliomyelitis by Feeding and by Contact Spread of Living Attenuated Virus Including Studies of Virus Properties After Human Intestinal Passage (1960) (20)
Vaccine production in human diploid cell strains. (1971) (20)
Central auditory imperception: a significant factor in congenital rubella deafness. (1970) (20)
Rubella: Epidemiology, virology, and immunology. (1967) (20)
Gonorrhea in Preschooland School-Aged Children: Report of the Prepubertal Gonorrhea Cooperative Study Group (1976) (20)
THE POLIOVIRUSES OF MAN * (1962) (19)
Studies on Hemagglutination by Rubella Virus.∗ (1967) (19)
The global pertussis initiative: Meeting report from the regional Latin America meeting, Costa Rica, 5-6 December, 2008 (2010) (19)
A practical guide to the diagnosis of congenital infections in the newborn infant. (1986) (19)
The efficacy of whole cell pertussis immunisation: collected data on a vaccine produced in France. (2001) (19)
Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville, Congo. 3. Safety and efficacy during the first 21 months of study. (1961) (19)
The National Vaccine Injury Compensation Program: Striking a Balance Between Individual Rights and Community Benefit. (2019) (18)
Diabetes Mellitus and Insipidus in Two Sisters (1963) (18)
The place of DTP/eIPV vaccine in routine pediatric vaccination (1994) (18)
False-positive human immunodeficiency virus screening test related to rabies vaccination. (1995) (18)
American Academy of Pediatrics. Committee on Infectious Diseases. Recommendations for using pneumococcal vaccine in children. (1985) (18)
Seroepidemiology of hepatitis A antibodies among children’s hospital staff (2002) (18)
Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings. (2020) (18)
Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis (1997) (18)
Hell's fire and varicella-vaccine safety. (1988) (18)
The RV144 Thai HIV vaccine trial (2010) (18)
Antibody-dependent cell-mediated cytotoxicity against varicella-zoster virus-infected targets (1982) (18)
An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecan (2016) (17)
Microbial evolution: antitoxin vaccines and pathogen virulence. (2002) (17)
Perinatal Human Immunodeficiency Virus Infection (1988) (17)
NATURAL KILLING OF CYTOMEGALOVIRUS‐INFECTED TARGETS IN RENAL TRANSPLANT RECIPIENTS (1984) (17)
Neonatal mastitis due to Escherichia coli. (1970) (17)
Falsely normal radionuclide scans for osteomyelitis. (1980) (17)
Congenital cytomegalovirus infection and its prevention. (2004) (17)
Progress in vaccine development for prevention of human cytomegalovirus infection. (1990) (16)
22 – Mumps vaccine (2013) (16)
Influenza virus-induced encephalopathy in mice: interferon production and natural killer cell activity during acute infection (1986) (16)
Commentary: Mumps vaccines: do we need a new one? (2013) (16)
Whither vaccines? (2017) (16)
Human immunodeficiency virus type 1 tat gene enhances human cytomegalovirus gene expression and viral replication. (1991) (16)
Rubella infection of human leukocytes. Chromosomal and viral studies. (1965) (16)
Growth of Rubella Virus in BHK21 Cells. II. Enhancing Effect of DEAE-Dextran, Semicarbazide and Low Doses of Metabolic Inhibitors.∗ (1967) (16)
Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. (1990) (16)
Haemophilus influenzae type b vaccines: lessons from the past. (1988) (16)
Inactivated mouse cytomegalovirus vaccine: preparation, immunogenicity, and protective effect. (1980) (15)
‘Red Book’ Update (1982) (15)
Immune-specific gamma interferon production correlates with lymphocyte blastogenesis (1986) (15)
Chronically persistent infection with human cytomegalovirus in human lymphoblasts. (1979) (15)
Intracellular forms of the parental human cytomegalovirus genome at early stages of the infective process. (1978) (15)
Haemagglutinin of Rubella Virus (1967) (15)
Persistence of antibodies after vaccination with living attenuated poliovirus. (1959) (15)
Routine immunization with orally administered attenuated poliovirus. A study of 850 children in an American city. (1960) (15)
The response of premature infants to infection with attenuated poliovirus. (1962) (15)
The science of vaccine safety: Summary of meeting at Wellcome Trust. (2020) (15)
The changing epidemiology of mumps in a high vaccination era. (2019) (15)
A trial of vancomycin for prophylaxis of infections after neurosurgical shunts. (1985) (15)
Trial of human diploid cell rabies vaccine in human volunteers. (1976) (14)
Resticted Growth of Human Cytomegalovirus in UV-lrradiated WI-38 Human Fibroblasts 1 (1975) (14)
Case presentation of calcaneonavicular coalition in monozygotic twins. (1996) (14)
Varicella vendetta: plotkin's plug. (1977) (14)
3 – Correlates of Protection (2018) (14)
Untruths and consequences: the false hypothesis linking CHAT type 1 polio vaccination to the origin of human immunodeficiency virus. (2001) (14)
Warts (1967) (13)
Influenza in Latin America: A report from the Global Influenza Initiative (GII). (2019) (13)
Vaccination with the CHAT strain of type 1 attenuated poliomyelities virus in Leopoldville, Belgian Congo. 1. Description of the city, its history of poliomyelitis, and the plan of the vaccination campaign. (1960) (13)
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers (2020) (13)
A CASE OF PLATELET TRANSFUSION‐RELATED SERRATIA MARCESCENS SEPSIS (1985) (13)
An attenuated rubella virus strain adapted to primary rabbit kidney. (1968) (13)
Meningococcal disease from the public health policy perspective. (2012) (13)
Immunisation against meningococcus B (2013) (13)
Rabies vaccination. (1978) (13)
Varicella vaccine: a point of decision. (1986) (13)
Susceptibility to diabetogenic virus: host versus pancreatic factors. (1980) (13)
Preparation of highly purified human cytomegalovirus envelope antigen. (1985) (13)
Current issues in evaluating the efficacy of oral poliovirus vaccine and inactivated poliovirus vaccine immunization (1991) (13)
Ultrastructural study on the sequence of human cytomegalovirus infection in human diploid cells (2005) (12)
Ten yearly yellow fever booster vaccinations may still be justified. (2018) (12)
SERONEGATIVITY AND PAEDIATRIC AIDS (1987) (12)
Modification of an Attenuated Type 2 Polio Vaccine Following Passage at 23°C.∗ (1963) (12)
The combination measles, mumps, rubella and varicella vaccine in healthy children. (1986) (12)
Where rubella is still a problem. (1999) (12)
Prevention of rabies in man. (1971) (12)
AIDS IN A CHILD WITHOUT ANTIBODY TO HIV (1987) (12)
Oxacillin-resistant coagulase-negative staphylococcal carriage rates in neonatal intensive care nurses and non-patient care hospital personnel. (1987) (12)
Multidisciplinary approach to understanding cytomegalovirus disease : proceedings of the Fourth International Cytomegalovirus Workshop: Multidisciplinary Approaches to Understanding CMV Disease, Paris, France, 19-21 April, 1993 (1993) (12)
Gonorrhea in preschool- and school-aged children. Report of the prepubertal gonorrhea cooperative study group. (1976) (12)
American Academy of Pediatrics Task Force on Pediatrics AIDS: Infants and children with acquired immunodeficiency syndrome: placement in adoption and foster care. (1989) (12)
Mumps: A Pain in the Neck. (2018) (11)
Variation of response in early life to vaccination with living attenuated polivirus and lack of immunologic tolerance. (1960) (11)
Vaccines in the 21st century. (2001) (11)
The status of cytomegalovirus vaccine. (1991) (11)
Sang Froid in a time of trouble: is a vaccine against HIV possible? (2009) (11)
Building on the success of the Expanded Programme on Immunization: enhancing the focus on disease prevention and control. (2011) (11)
Vaccination of children with human cell culture rabies vaccine (1979) (11)
Rubella Eradication: Not Yet Accomplished, but Entirely Feasible (2021) (11)
Imipenem/cilastatin for the treatment of infections in hospitalized children. (1985) (11)
Indirect Hemagglutination Test for Varicella-Zoster Infection (1972) (11)
Intranasal vaccination with RA 27-3 attenuated rubella virus. (1971) (11)
American Academy of Pediatrics Committee on Infectious Diseases: Prevention of hepatitis B virus infections. (1985) (11)
The effectiveness of whole-cell pertussis vaccines. (1997) (11)
THE RESPONSE OF PREMATURE INFANTS TO INFECTION WITH TYPE 3 ATTENUATED POLIOVIRUS. (1964) (10)
Haemophilus influenzae Type b Conjugate Vaccines: Update (1989) (10)
Preventing Infection by Human Cytomegalovirus. (2020) (10)
The A-B-O blood groups in relation to prematurity and stillbirth. (1958) (10)
Cervical adenitis caused by anaerobic bacteria (1976) (10)
Clinical comparison of preinjection anesthetics. (1998) (10)
Vaccines Against Human Hookworm Disease (2004) (10)
Excretion of human immunodeficiency type 1 in the throat but not in urine by infected children. (1991) (10)
Susceptibility of vaccine strains of varicella-zoster virus to antiviral compounds (1984) (10)
Growth of Rubella Virus in BHK21 Cells. III. Production of Complement-Fixing Antigens.∗ (1967) (10)
American Academy of Pediatrics Task Force on Pediatric AIDS: Guidelines for human immunodeficiency virus (HIV)-infected children and their foster families. (1992) (10)
Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses. (1994) (10)
Relapse of pneumonia caused by cytomegalovirus in two recipients of renal transplants. (1979) (9)
CYTOMEGALOVIRUS VACCINATION AND RENAL TRANSPLANTATION (1978) (9)
Controlling pertussis: considerations for the future. (2005) (9)
29 – Rabies vaccines (2013) (9)
Cytomegalovirus vaccine prepared in WI-38. (1976) (9)
Vaccination Against Measles in the 18th Century (1967) (9)
Serially cultured animal cells for preparation of viral vaccines. (1969) (9)
Oral poliovirus vaccination in newborn African infants: relative ineffectiveness of early feeding of vaccine. (1968) (9)
The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries. (2002) (9)
The Growth of Varicella-Zoster Virus in Guinea Pig Embryo Cells (1973) (9)
Effects of Interferon on Natural Killing and Antibody-Dependent Cellular Cytotoxicity Against Varicella-Zoster Virus-Infected and Uninfected Target Cells (1983) (9)
Hemophilus Influenzae Septic Arthritis in Infants and Children (1975) (9)
Commentary: Is Japan deaf to mumps vaccination? (2009) (9)
New rotavirus vaccines. (2006) (9)
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005. (2007) (9)
Recent results of mass immunization against poliomyelitis with Koprowski strains of attenuated live poliovirus. (1962) (9)
IMMUNE RESPONSES IN CHILDREN WITH CONGENITAL CYTOMEGALOVIRUS AND THEIR MOTHERS (1977) (9)
Combination vaccines and immunization visits. (1996) (9)
Rubella vaccine. (1972) (8)
Vaccination against herpes group viruses. (1975) (8)
Cytomegalovirus in hospitals (1986) (8)
Food poisoning in infants caused by egg-yolk powder. (1954) (8)
ANTIBODY RESPONSE OF MAN TO CANINE DISTEMPER VIRUS (1960) (8)
Determination of N-formimidoylthienamycin concentration in sera from pediatric patients by high-performance liquid chromatography. (1986) (8)
Acyclovir therapy in neonatal herpes simplex virus infection. (1982) (8)
Ampicillin-resistant, beta-lactamase-negative haemophilus influenzae type b. (1982) (8)
Postscript relating to new allegations made by Edward Hooper at The Royal Society Discussion Meeting on 11 September 2000. (2001) (8)
The pathogenesis and prevention of human cytomegalovirus infection (1984) (8)
Rapid detection of cytomegalovirus infections by a tissue culture-centrifugation-monoclonal antibody-biotin/avidin immunofluorescence technique. (1987) (8)
John Snow learns from Louis Pasteur. (2001) (8)
Further studies of an attenuated rubella strain grown in WI-38 cells. (1969) (8)
Detection of antibodies to pre-early nuclear antigen and immediate-early antigens in patients immunized with cytomegalovirus vaccine (1982) (8)
Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines (2021) (8)
Cytotoxic T Lymphocyte ( CTL ) Responses to Human Cytomegalovirus pp 65 , IE 1-Exon 4 , gB , pp 150 , and pp 28 in Healthy Individuals : Reevaluation of Prevalence of IE 1-Specific CTLs (8)
[New vaccination strategies]. (2008) (8)
Human capital gaps in vaccine development: an issue for global vaccine development and global health (2017) (8)
Measles: Breakouts and Breakthroughs. (2019) (8)
The New Coronavirus, the Current King of China (2020) (8)
The N-terminal 303 amino acids of the human cytomegalovirus envelope glycoprotein B (UL55) and the exon 4 region of the major immediate early protein 1 (UL123) induce a cytotoxic T-cell response. (1996) (8)
Pertussis: pertussis control strategies and the options for improving current vaccines (2014) (8)
Infection and atherosclerosis (1999) (8)
Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative. (2012) (8)
Inhibition of human cytomegalovirus by rifampin. (1975) (8)
Enhanced poliovirus replication in cytomegalovirus-infected human fibroblasts. (1978) (7)
Comprar Vaccines, 5th Edition: Expert Consult | Paul A. Offit | 9781416036111 | Saunders (2008) (7)
A hepatitis B vaccine with a novel adjuvant. (2013) (7)
Protracted mononucleosis-like illness associated with acquired cytomegalovirus infection in a previously healthy child: transient cellular immune defects and chronic hepatopathy. (1991) (7)
Monoclonal antibodies directed to two groups of viral proteins neutralize human cytomegalovirus in vitro. (1987) (7)
No evidence to link polio vaccine with HIV ... (2000) (7)
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on new and useful techniques in rapid viral diagnosis. (1980) (7)
History of Rubella Vaccines and the Recent History of Cell Culture (2011) (7)
Rotavirus-specific antibodies in fetal bovine serum and commercial preparations of serum albumin (1984) (7)
Nouvelles stratégies de la vaccination (2008) (7)
Enhanced severity of experimental Herpes simplex infection in mice fed a protein-free diet. (1967) (7)
Isolation and characterization of an infectious molecular clone of the MN strain of HIV-1. (1991) (6)
A Population-Based Threshold of Protection for COVID-19 Vaccines (2021) (6)
Cerebral cysticercosis. (1979) (6)
Calculation of the spectral absorption curves for nitrogen-bearing compounds based on a computer library (1989) (6)
Progress toward developing a cytomegalovirus vaccine. (1990) (6)
Restriction endonuclease patterns of cytomegalovirus after passage in humans. (1987) (6)
Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: “The BraCHS Study,” by Mussi-Pinhata et al (2018) (6)
“ Variolation ” and Vaccination in Late Imperial China , Ca 1570 – 1911 (2018) (6)
Rabies vaccination in the 1980s. (1980) (6)
Birth and death of congenital rubella syndrome. (1984) (6)
Booster vaccination at 1 year with a rabies vaccine associated with DTP-IPV in infants living in a rabies endemic country. (1999) (6)
Cytological Virological and Chromosomal Studies of Cell Strains From Aborted Human Fetuses.∗ (1966) (6)
Enhancement of Infectivity of Cell-Free Varicella-Zoster Virus with Diethylaminoethyl-Dextran (1981) (6)
Preventing harm from thimerosal in vaccines [3] (multiple letter) (2000) (6)
Clinical and pathogenetic aspects of varicella-zoster. (1985) (6)
Mining the mechanisms of an HIV vaccine (2012) (5)
Rabies risk and immunoprophylaxis in children. (1997) (5)
Vaccines We Need But Don't Have. (2017) (5)
COVID-19 vaccine delivery: an opportunity to set up systems for the future. (2020) (5)
Effect of neonatal corticoid treatment on tryptophan and serotonin metabolism. (1978) (5)
SARS-CoV-2 vaccine development (2020) (5)
Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection. (2020) (5)
Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration (1992) (5)
New Vaccine Development, Establishing Priorities, Diseases of Importance to the United States (1987) (5)
Emergence and Control of Viral Respiratory Diseases (2005) (5)
Evaluation of Abbott CMV-M enzyme immunoassay for detection of cytomegalovirus immunoglobulin M antibody (1988) (5)
Production of RA27/3 rubella vaccine and clinical results with the vaccine. (1976) (5)
The Importance of Persistence (2016) (5)
Perinatally acquired viral infections. (1977) (5)
Commentary: In Memoriam: Hilary Koprowski, 1916–2013 (2013) (5)
Application of a human osteogenic sarcoma cell culture for detection of human cytomegalovirus antibody by immunofluorescence tests (1981) (5)
Dengue Vaccine, A Double-Edged Sword. (2020) (5)
The new decade of vaccines – Authors' reply (2012) (5)
Natural vs vaccine-acquired immunity to cytomegalovirus. (2003) (5)
Zika as still another argument for a new path to vaccine development (2016) (5)
Is There a Correlate of Protection for Measles Vaccine? (2019) (5)
History of vaccines (2015) (4)
Delayed type hypersensitivity to human cytomegalovirus (1993) (4)
Prevention of Cytomegalovirus Infection (1984) (4)
In utero fetal lower extremity examination by diagnostic ultrasound. (1988) (4)
Extraintestinal shigellosis: bacteremia and paroxysmal atrial tachycardia. Shigella sonnei in a three-year-old boy. (1973) (4)
Behaviour of rubella virus in human diploid cell strains II. Studies of infected cells (2005) (4)
Antiplatelet antibodies during the course of HIV-preventive vaccine trial. (1996) (4)
Rubella in the distant past as a possible cause of congenital malformations. (1970) (4)
Vaccination by the intranasal route. (1969) (4)
The structure of linear polyallyl esters of maleic acid (1967) (4)
Third Dose of MMR Vaccine for Mumps Control. (2017) (4)
Meningococcal control in the United States and Africa. (2006) (4)
Action du virus de la rubéole sur différents systèmes de cultures de cellules embryonnaires humaines (2005) (4)
Unsung Hero Robert C. Gallo (2009) (4)
Prediction of the IR spectra of polystyrene and its deuterated analogs (1989) (4)
COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies (2021) (4)
The future of varicella vaccine. (1985) (4)
Composition of pertussis vaccine given to infants determines long-term T cell polarization (2018) (4)
Fatal gonococcal septicemia. (1985) (4)
Chimpanzees and journalists. (2004) (4)
Management of heel pain syndrome with acetic acid iontophoresis. (1999) (4)
Developments in immunization practices and strategies: implications for vaccine stability. (1996) (4)
The Choice Between Killed- and Live-Virus Poliomyelitis Immunization (1963) (4)
The Oklahoma-Kansas anthrax epizootic of 1957. (1959) (4)
DNA synthesis in chromatin preparations from human fibroblasts infected by cytomegalovirus (2005) (4)
Vaccination ecosystem health check: achieving impact today and sustainability for tomorrow (2017) (4)
Immunology of Cytomegalovirus (1982) (4)
Letter: Administration of oral polio vaccine in relation to time of breast feeding. (1974) (4)
Varicella-Zoster Virus: Development of the Oka vaccine (2000) (4)
The influence of interval between doses on response to vaccines (2021) (4)
Behaviour of rubella virus in human diploid cell strains I. Growth of virus (1967) (4)
Serologic survey of antibodies to cytomegalovirus in women and infants in Lima, Peru. (1983) (4)
Hypolycorrhachia in young infants with viral meningitis (1975) (4)
Problems in vaccine development. (2014) (4)
Generation of deletion mutants of simian immunodeficiency virus incapable of proviral integration (1993) (4)
Plaquing of rubella virus in RK 13 cells (2005) (3)
Cendehill strain of rubella vaccine: clinical evaluation. (1969) (3)
Chapter 19 - Viral Vaccines: Fighting Viruses with Vaccines (2016) (3)
Responding to The River (1999) (3)
Rubella vaccines. (1967) (3)
NIAID workshop on secondary vaccine effects (2021) (3)
New rabies vaccine. (1981) (3)
Case 4-2018: A Newborn with Thrombocytopenia, Cataracts, and Hepatosplenomegaly. (2018) (3)
American Academy of Pediatrics Committee on Infectious Diseases: Parvovirus, erythema infectiosum, and pregnancy. (1990) (3)
Cyclic polymerization of diallyl maleate (1964) (3)
Vaccination Against SARS-2-nCoV. (2020) (3)
Pediatric Combination Vaccines (1999) (3)
Preventing harm from thimerosal in vaccines. (2000) (3)
Formation of covalently closed cyclic dimers and catenanes of Escherichia coli phage lambda in the absence of known recombination systems. (1976) (3)
Vaccines: facing complex problems with the promise of immunology (2014) (3)
Congenital transmission of HHV-6. (2008) (3)
Genetic changes in attenuated poliovirus strains cultivated on human intestine in vitro. (1968) (3)
Prevention of cytomegalovirus disease (1984) (3)
Evolving measles status and immunization policy development in six European countries (2022) (3)
41 – Biodefense and special pathogen vaccines (2013) (3)
1056 ADVANCES KITH THE VARICELLA VACCINE: A TRIAL OF THE TETRAVAIENT VACCINE (MMRV) AND A POST EXPOSURE PROPHYLAXIS STUDY (1985) (3)
Stimulation of macro molecular synthesis in guinea pig cells by human cytomegalovirus (1975) (3)
1076 ROTAVIRUSES (RV) OF BOVINE AND HUMAN ORIGIN: IMMUNE RESPONSE OF ADUIITS AND CHILDREN FOLLOWING ORAL ADMINISTRATION (1985) (3)
Commentary: congenital rubella syndrome should not be a disease of poor countries. (2004) (3)
Biodefense and Special Pathogen Vaccines (2017) (3)
Extraintestinal Shigellosis: Bacteremia and Paroxysmal Atrial Tachycardia (1973) (3)
Prevention of intrauterine and perinatal infections. (1981) (3)
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation (2022) (3)
Immunity to rubella: comparison between naturally and artificially induced resistance. (1972) (3)
Of vaccination and infectious diseases in 2003. (2004) (3)
Recurrent conjunctivitis in neonatal herpes infection. (1983) (2)
Meta-analysis of typhoid vaccine efficacy trials showed that whole cell vaccines are more effective than either the oral, attenuated vaccine or the Vi polysaccharide vaccine. (1999) (2)
Effect of Cold Passage on Reproductive Capacity at Various Temperatures of Several Type 3 Poliovirus Strains.∗ (1963) (2)
Acute infectious diarrhea of children in the tropics. (1982) (2)
Human skin fibroblasts are nonpermissive to coxsackie B4 infection: an age-dependent phenomenon. (1983) (2)
Measles, Mumps, and Rubella (2010) (2)
Problems in the choice of combined vaccines for Europe. (1994) (2)
Commentary: Cuba libre de poliovirus. (2001) (2)
RUBELLA VACCINATION (1979) (2)
752 NAFCILLIN-OXACILLIN COMPARATIVE CLINICAL TRIAL (1978) (2)
The future of vaccines against viral diseases. (1968) (2)
The importance of immunologic factors in the pathogenesis of encephalomyocarditis virus induced diabetes in mice. (1984) (2)
Vaccines in the 21st century. (2002) (2)
The scourge of vaccine falsification (2022) (2)
Inhibition of rubella virus by amantadine (2005) (2)
Poliovirus vaccine and vaccine-derived polioviruses. (2010) (2)
FIRST RESULTS OF THE FEASIBILITY OF PRE-EXPOSURE RABIES VACCINATION ASSOCIATED WITH DTP-IPV DURING EPI SESSIONS IN INFANTS LIVING IN AN ENDEMIC COUNTRY. • 1046 (1996) (2)
A new rabies vaccine. (1981) (2)
43 – Cytomegalovirus vaccines (2013) (2)
PROTECTION AFFORDED BY WC3 ROTAVIRUS VACCINE AGAINST NATURAL (PREDOMINANTLY SEROTYPE 1) ROTAVIRUS INFECTION IN A PLACEBO-BLINDED EFFICACY TRIAL (1987) (2)
The late sequelae of Arrowsmith. (2002) (2)
Live varicella vaccine: the third act? (1986) (2)
What have we learned from the COVID-19 plague? (2021) (2)
American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: immunization of children at 15 months of age. (1990) (2)
Letter: Hypoglycorrachia in young infants with viral meningitis. (1975) (2)
Vaccination against Herpes group viruses, in particular, cytomegalovirus. (1979) (2)
Conclusions to the conference on orphan vaccines. (2002) (2)
Reply to Gantt et al., “Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection” (2018) (2)
Cytomegalovirus vaccine development--past and present. (1991) (2)
Congenital cytomegalovirus infection associated with multicystic kidney. (1969) (2)
Robert Austrian: 1917–2007 (2007) (2)
Robert Austrian: 1917–2007 (2007) (2)
The Facts About Vaccine Safety. (2020) (2)
First reported successful management of Serratia marcescens bacteremia after open heart surgery in a child. (1975) (2)
The Influenza Vaccine Mess. (2018) (2)
Vaccine Strategies for the Prevention of Cytomegalovirus Disease (1993) (2)
Vaccine mandates in France will save lives (2018) (2)
Phobia of hydrophobia justified. (1979) (2)
Systhesis of linear polymers from monoallyl esters of unsaturated acids by the cyclic polymerization mechanism (1963) (2)
New developments in vaccines. (1991) (2)
COVID-19 vaccine delivery: an opportunity to set up systems for the future (2021) (1)
Intravenous γ-Globulin Use in Children With Kawasaki Disease (1988) (1)
An overview of current vaccine development (1998) (1)
Postnatal Rubella in the Presence of Antibody (1967) (1)
Chikungunya Virus: A Back-Breaking Problem. (2019) (1)
Choosing the Right Path toward Polio Eradication. (2023) (1)
Tracheal colonization and infection in a pediatric intensive care unit (1980) (1)
Recognize Congenital Rubella (1969) (1)
Effect of DNA polymerase inhibitors on the replication of human cytomegalovirus (2005) (1)
Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines. (2018) (1)
HIV SCREENING IN PREGNANCY. REPLY (1991) (1)
Modification of an attenuated type 2 polio vaccine following passage at 23degreeC. (1963) (1)
The Outcome of Staphylococcal Bacteremia in Childhood (1976) (1)
Therapeutic vaccines and immunotherapies: current challenges and new frontiers (2013) (1)
False-Normal Radionuclide Scans for Osteomyelitis-Reply (1981) (1)
Calculation of the spectral distribution of the absorption coefficient of phenylacetonitriles (1991) (1)
"The Duesberg phenomenon": Duesberg and other voices (1995) (1)
Intranasal administration of RA 27/3 rubella virus vaccine. A clinical trial in young adults. (1984) (1)
The Facts About Vaccine Safety. (2021) (1)
The pathogenesis and prevention of human cytomegalovirus infection. Report of a conference. (1984) (1)
Measles Vaccine Schedules (1968) (1)
COMPARISON OF VACCINE-INDUCED AND NATURAL IMMUNITY TO HUMAN CYTOMEGALOVIRUS (CMV) (1987) (1)
The Value of Human Challenges in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development (2020) (1)
Intratypic sero-differentiation of polioviruses. (1961) (1)
Preface to the Seventh Edition (2018) (1)
Half-Dose Immunization for Diphtheria, Tetanus, Pertussis (1990) (1)
Tetanus andDiphtheria Boosters. (2020) (1)
[Mass vaccination of school children with live vaccine against poliomyelitis]. (1961) (1)
A PROSPECTIVE STUDY OF THE USE OF FROZEN-THAWED WASHED RED BLOOD CELLS (FTW-RBC) TO PREVENT TRANSFUSION-ACQUIRED CMV INFECTION (TA-CMVI) IN THE NEONATE (1984) (1)
Obituary of Maurice Hilleman (2006) (1)
Minitransfection: a simple, fast technique for transfections. (1991) (1)
Progress in vaccination (2014) (1)
Inhalation anthrax revisited: a note from the original authors (2002) (1)
Live Cytomegalovirus Vaccination of Renal Transplant Candidates (2020) (1)
Lemons and Lyme. (2018) (1)
Antibiotics-1968 (1968) (1)
Polio eradication vaccine investment: how do we ensure polio vaccines are available to keep the world polio-free after transmission of wild poliovirus (wPV) has been interrupted? (2021) (1)
Recent updates on correlates of vaccine-induced protection (2023) (1)
Comparison of complement fixation and fluorescent immunoassay (FIAX) for measuring antibodies to cytomegalovirus and herpes simplex virus. (1981) (1)
Hemophilus influenzae Epiglottitis Occurring Concurrently in Two Siblings (1982) (1)
Non è Vero, è Mal Trovato: Polio Vaccine is not the cause of HIV (2004) (1)
Orally administered antibiotics for suspected bacteremia. (1981) (1)
Portait of an ISV fellow (2018) (1)
Experiences With A Multiple Resistant Klebsiella pneumonias In An Infant Intensive Care Unit (1977) (1)
Titerphilia - The Irresistible Urge to Measure Postimmunization Antibody Values. (2022) (1)
Chapter 4 Rubella Vaccine (2006) (1)
ORAL POLIOMYELITIS VACCINE (1962) (1)
HIV vaccine development at the turn of the 21 st century opyright (2011) (1)
Use of meta-analysis to draw conclusions as to relative efficacy is illegitimate and should not be accepted. (2000) (1)
American Academy of Pediatrics Committee on Infectious Diseases: Family history of convulsions in candidates for immunization with pertussis-containing vaccines (diphtheria, tetanus, pertussis). (1987) (1)
DISEASE STATES AND VACCINES: SELECTED CASES (2003) (1)
A hundred years of vaccination: the legacy of Louis Pasteur. (1996) (1)
World's debt to Pasteur : proceedings of the centen[n]ial symposium commemorating the first rabies vaccination held in Philadelphia, Pennsylvania, January 17 and 18, 1985 (1985) (1)
Perspectives en vaccinologie (1994) (1)
Synthèse des données récentes (2004) (1)
How to Prepare for Expert Testimony on the Safety of Vaccination (2019) (1)
An anthrax vaccine was evaluated clinically and epidemiologically in an exposed, susceptible, and supervised population. Findings are reported and the authors suggest exposed populations for whom the vaccine is recommended. FIELD EVALUATION OF A HUMAN ANTHRAX VACCINE (1962) (1)
Antibiotics 1970 (1970) (1)
The status of cytomegalovirus vaccine. Discussion (1991) (1)
Human cytomegalovirus vaccine is an orphan. (2002) (1)
Addressing Concerns of Pediatric Trainees Caring for Patients With Human Immunodeficiency Virus Infection (1993) (1)
DERMAL REACTIVITY TO HUMAN CYTOMEGALOVIRUS (CMV) (1987) (0)
How and why vaccines are made (2005) (0)
Cendebill strain of rubella Clinical evaluation (1969) (0)
Vaccines: From the research laboratory to their use in the field (1985) (0)
CYTOMEGALOVIRUS INFECTION AND RENAL TRANSPLANTATION (1988) (0)
Two Hundred Twenty Years of Vaccination 1 (2018) (0)
Public hearing transcript: Federal non-nuclear energy research and development program (1978) (0)
Stanley Alan Plotkin's Development of a Rubella Vaccine (1969) (2018) (0)
The efficacy of whole cell pertussis immunisation (2001) (0)
American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: update. (1989) (0)
CYTOMEGALOVIRUS INFECTION IN UTERO (1974) (0)
[Tropical vaccinology at the dawn of the 21st century]. (2007) (0)
Perinatal Human Immunodeficiency Virus ( HIV ) Testing Services (2006) (0)
Vaccin de cytomegalovirus recombinant (1990) (0)
[ESTABLISHMENT OF HUMAN DIPLOID EMBRYO CELL STRAINS CHRONICALLY INFECTED BY THE RUBELLA VIRUS]. (1964) (0)
In Reply: Questions About Varicella Vaccine (1996) (0)
Clinical development of a new inactivated hepatitis A vaccine. (1996) (0)
Infants at risk for the acquired immunodeficiency syndrome. (1992) (0)
Fundamentalist and eschatologic approach to ethics. (1972) (0)
Prevention of cytomegalovirus disease. Report of a conference. (1984) (0)
[CHROMOSOME CHANGES INDUCED BY THE RUBELLA VIRUS IN HUMAN DIPLOID EMBRYO CELLS CULTIVATED IN VITRO]. (1964) (0)
Cytomegalovirus vaccine. (1999) (0)
Stark abgeschaechter megalozytenvirusimpfstoff and its production (1975) (0)
From the American Academy of Pediatrics: 1. Guidelines for HIV-infected children and their foster families (1992) (0)
John Beale 1923–2005 (2006) (0)
An epidemic and social taboos (2011) (0)
Precision Vaccines: Lessons Learned From the Coronavirus Pandemic (2022) (0)
Antibiotics—1975 (1975) (0)
Rubella vaccine. (1970) (0)
Preclinical and clinical development of new vaccines, Institut Pasteur, Paris, France, 27-28 May 1997. (1998) (0)
IATROGENIC DISEASE CAUSED BY DETERGENTS (1960) (0)
[Immunization of 850 children of Philadelphia with attenuated poliomyelitis virus. Preliminary report]. (1961) (0)
PUBLIC PERCEPTION OF VACCINE DANGERS : WHAT IS THE CAUSE FOR CONCERN ? (2011) (0)
2. Perinatal human immunodeficiency (HIV) testing (1992) (0)
Biographical Memoirs: Robert Austrian (2009) (0)
Comprar Vacunas | Stanley A. Plotkin | 9789507623240 | AWWE (2007) (0)
POLIO IMMUNIZATION OF AN ADOLESCENT (1988) (0)
More than trial and error. (2011) (0)
Immune Prophylaxis and Vaccinations (2002) (0)
An end to Manicheism. (1993) (0)
Of underimmunization and underfunding. (1990) (0)
In Reply: HIV Screening in Pregnancy (1991) (0)
Preface to the fifth edition (2008) (0)
[Pediatric vaccines tomorrow]. (1996) (0)
Human diploid cell strains (HDCS) viral vaccines : Safety of Biological Products Prepared from Mammalian Cell Culture (1998) (0)
Festschrift for Professor Margaret Burgess AO Festschrift for Professor Margaret Burgess AO (2005) (0)
Life with the pneumococcus. Notes from the bedside, laboratory and library: R. Austrian, University of Pennsylvania Press, Philadelphia, Pennsylvania, USA, 1985, 168 pp., US$25 (1987) (0)
In Memoriam (2012) (0)
The history of vaccination against cytomegalovirus (2015) (0)
Induction of Bordetella pertussis-specific immune memory by DTPa vaccines. (2011) (0)
Live attenuated varicella vaccine." of healthy children with the OKA Immunization strain (1982) (0)
Antibiotics 1973. (1973) (0)
Virologic assistance in the management of German measles in pregnancy (2005) (0)
Recombinant vaccine rotavirus. (1991) (0)
Attenuated Poliomyelitis Virus in Leopoldville, Belgian Congo* (2008) (0)
3. Education of children with human immunodeficiency virus infection (1992) (0)
Molecular genetics of the rotaviruses. (1990) (0)
Rubella vaccination. (1971) (0)
Letter: Cervical adenitis caused by anaerobic bacteria. (1976) (0)
Natural vs vaccine-acquired immunity to cytomegalovirus. Author's reply (2003) (0)
Ethical considerations in the vaccine life cycle : an overview (2013) (0)
Rubella vaccination. (1979) (0)
The anti-inflammatory action of locally injected ketorolac. (1998) (0)
Letter to the editor of REGULATION. (2003) (0)
Cytomegalovirus vaccine update (1981) (0)
The enemy is sometimes us (2010) (0)
Manipulation of the immune system alters susceptibility to virally induced diabetes. Abstr. (1981) (0)
Successes and failures with vaccines (2019) (0)
Poliovirus vaccine inactivated (2015) (0)
Infectious Disease Specialists: Practice What You Preach. (2017) (0)
Antibiotics 1971 (1971) (0)
Poliomyelitis: do we need to immunize the newborn? (1972) (0)
of Human Leukocytes Chromosomal and Viral Studies (2017) (0)
16 – Cytomegalovirus Vaccines (2018) (0)
Clinical and Immunologic Biomarkers for Regression of High Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 Infection after Immunotherapy with VGX-3100 in a Phase IIb Clinical Trial (2017) (0)
Les vaccins du 21ème siècle (2001) (0)
Les vaccins pédiatriques de demain (1996) (0)
Vaccin contenant un cytomegalovirus de recombinaison (1994) (0)
Etude de la reponse immune au vaccin rotavirus vivant attenue, souche WC3, chez des enfants de 2 A 12 mois* (1989) (0)
Développement du vaccin pneumocoque conjugué undécavalent (2000) (0)
La vaccination antipoliomyélitique n'a pas transmis le sida à l'homme. Origine du sida : La fin d'une polémique ? (2001) (0)
Vaccin recombine contre le cytomegalovirus (1994) (0)
Le vaccin oral anti-polio CHAT n'est pas à l'origine de la contamination humaine par le HIV de type 1 groupe M (2002) (0)
Pneumocystis carinii Pneumonia (1978) (0)
1004 VACCINATION OF PEDIATRIC NURSES WITH TOWNE STRAIN CYTOMEGALOVIRUS (CMV) (1981) (0)
Défense du challenge humain dans le contexte de la Covid‑19 (2021) (0)
Vibrational spectra of nitrogen-containing six-membered heterocyclic compounds (1988) (0)
Organization of a computer library for predicting spectra of poly (vinylpyridines) (1990) (0)
Theoretical investigation of influence of polypropylene chain length on the shaping of contours of absorption band envelopes (1990) (0)
Springtime Again? Novel Strategies (2017) (0)
Antibiotics—1969 (1969) (0)
Combination strategies for vaccination against HIV. (1996) (0)
Congenital Transmission of HHV-6. Authors' reply (2008) (0)
Theoretical investigation of the effect of the conformation and length of a chain on the calculation of the spectral absorption coefficient of polypropylethylene (1993) (0)
MORE ON RETICULOSE (1962) (0)
Prediction of IR absorption spectral curves of alkylpyridines (1988) (0)
Theoretical analysis of vibrational spectra of polymethylstyrenes using a machine library (1989) (0)
Influence of conformation and chain length on results of calculation of the spectral absorption coefficient of polyethylethylene (1992) (0)
1052 Rapid detection of human cytomegalovirus (1985) (0)
Mumps Vaccine. (1968) (0)
The virus susceptibility of skin‐derived fibroblasts from families with insulin‐dependent diabetes mellitus (1982) (0)
The past, present and future of vaccination (2007) (0)
Infants and Children With Acquired Immunodeficiency Syndrome: Placement in Adoption and Foster Care (1990) (0)
Perinatal Human lmmunodeficiency Virus Infection (2006) (0)
Progress in vaccinology, vol. 2: Editor, G.P. Talwar, Springer-Verlag, New York, 1989, 483 pp., DM 298 (1990) (0)
Antibiotics, 1972 (1972) (0)
The crisis at Guy's. (1960) (0)
1051 Efficacy and Safety of Imipenem in Childhood (1985) (0)
Editorial comment: antiviral chemotherapy. (1972) (0)
The world needs to prepare now to prevent polio resurgence post eradication (2022) (0)
Obituary of Robert Daum - Expert in Staphylococcal Disease (2022) (0)
Vaccine Decision-making in a Time of Conflicting Recommendations: A Call to Go Beyond Politics (2023) (0)
WITHDRAWN: Letter to the Editor. (2011) (0)
Letter: Cytomegalovirus infection in utero. (1974) (0)
Vaccines: life savers and controversy makers Arthur Allen (2007) (0)
Pediatric Vaccines 2005 (2005) (0)
Serologic Tests for COVID-19 Infections and Vaccination (2022) (0)
Contents, Vol. 19, 1983 (1983) (0)
Intranasal raccination n ith RA attenuated rubella rirus (1971) (0)
Generation ofDeletion Mutants ofSimian Immunodeficiency Virus Incapable ofProviral Integration (1992) (0)
Strategies for the Development of New Vaccines (2010) (0)
Lyme Disease Vaccine (2007) (0)
Disease Prevention Accelerating Next-Generation Vaccine Development for Global (2013) (0)
Diabetes mellitus and congenital rubella. (1970) (0)
Title Page / Contents / Contributors / Preface (1972) (0)
Human immunodeficiency virus and artificial feeding. (1989) (0)
Herpes simplex virus type 2 infection of neonatal mice (2005) (0)
A Comparison of Herpes Simplex Virus (HSV) Typing Using Direct Fluorescent Antibody (DFA) and Chick Embryo Plaque (CEP) Assays (1979) (0)
Why We Need Precision Vaccinology (2022) (0)
Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development (2023) (0)
[Vaccination perspectives]. (1994) (0)
Vaccines handbook : mobile version : a companion to Plotkin, Orenstein's and Offit's Vaccines (2009) (0)
[PART I Introduction] (2005) (0)
Preface by Editor in Chief (2013) (0)
CVM: pathogenesis and prevention of human infection. International workshop held April 20-22, 1983 at the Children's Hospital of Philadelphia, PA. (1984) (0)
The History of Vaccines.org publishes a book. (2013) (0)
Subject Index, Vol. 19, 1983 (1983) (0)
Review of Progress: Antibiotics, 1967 (1967) (0)
The state of the field. Interview by Regina McEnery. (2008) (0)
Sgot Elevations and Hepatitis B Infections in Hemophiliacs (1977) (0)
Torch rerevisited. (1989) (0)
[INHIBITORY ACTION OF THE MEASLES VIRUS ON THE MULTIPLICATION OF DIFFERENT HUMAN EMBRYONAL CELLS CULTIVATED IN VITRO]. (1964) (0)
Cytomegalovirus vaccines. (1981) (0)
New Antibiotics and Old Diseases (1977) (0)
Partially treated bacterial meningitis (1974) (0)
Stanley Alan Plotkin (1932– ) (2020) (0)
950 ADENOVIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME IN A BONE MARROW TRANSPLANT PATIENT (1985) (0)
Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (2020) (0)
CMV vaccine: a response to criticism. (1978) (0)
NEW HUMAN TISSUE CULTURE VACCINE AGAINST RABIES (1974) (0)
Vaccination against human cytomegalovirus with live virus. (1982) (0)
Status of rubella vaccines (1981) (0)
Dengue vaccines: the road to failure or to success? (2020) (0)
The Value of Human Challenges in SARS-2-nCoV Vaccine Development. (2020) (0)
[Vaccination against rubella]. (1967) (0)
Polio vaccine production. (1997) (0)
769 A CYTOMEGALOVIRUS VACCINE TRIAL IN RENAL TRANSPLANT CANDIDATES (1978) (0)
Obituary of Robert Daum - Expert in Staphylococcal Disease (2022) (0)
Third Dose of MMR Vaccine for Mumps Control. (2017) (0)
Comprar History of Vaccine Development | Plotkin, Stanley A. | 9781441913388 | Springer (2010) (0)
How to reconize congenital rubella. (1969) (0)
Vaccine design F. Brown, G. Dougan, E. M. Hoey, S. J. Martin, B. K. Rima and A. Trudgett. John Wiley & Sons, Chichester (1993). 136 pp. ISBN 0–47193–727–4 (1994) (0)
Letter: Partially treated bacterial meningitis. (1974) (0)
Preface to the sixth edition (2013) (0)
1049 An outbreak of cryptosporidiosis in a day care center (1985) (0)
GrowthCharacteristics ofCytomegalovirus in HumanFibroblasts withDemonstration of Protein Synthesis Early inViral Replication (1973) (0)
MUCOSAL ANTIBODIES TO CYTOMEGALOVIRUS (CMV) GLYCOPROTEIN B (gB) OCCUR FOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH CMV VACCINES.• 973 (1996) (0)
Mass Inoculation of Schoolchildren With Live Polio Vaccine. (1961) (0)
Viral Vaccine meeting held in Barcelona, October 25–28, 2003 (2004) (0)
The new decade of vaccines Reply (2012) (0)
33 A Mitotic Inhibitor Produced by Rubella Virus Infection of Human Fibroblasts (1967) (0)
Bali Low. (1997) (0)
Can We Prevent Congenital Infection By Cytomegalovirus? (2023) (0)
Do Vaccines Cause That?! By Martin G. Myers and Diego Pineda. Galveston, TX: i4ph, 2008. 268 pp., Illustrated. $14.95 (paperback) (2008) (0)
[ACTION OF THE RUBELLA VIRUS ON DIFFERENT SYSTEMS OF HUMAN EMBRYONIC CELL CULTURES]. (1965) (0)
Chromosomes in human leukocytes infected with rubella virus (1965) (0)
A New Lyme Disease Vaccine is a Priority (2009) (0)
Providing MMR vaccine to children. (1991) (0)
968 IMMUNE-SPECIFIC GAMMA INTERFERON (IFN) PRODUCTION CORRELATES WITH LYMPHOCYTE BLASTOGENESIS (1985) (0)
Vaccination against rubella with tissue culture-adapted living virus (1965) (0)
A Précis and Perspective of the Phylogeny of the Pediatric Infectious Diseases Society. (2012) (0)
Monoplegia and diplegia during an outbreak of enteroviral meningoencephalitis (1988) (0)
[Preliminary study of an attenuated varicella-zoster vaccine (Webster strain) in 27 children without immunologic disorders]. (1983) (0)

This paper list is powered by the following services:

Other Resources About Stanley Plotkin

en.wikipedia.org

What Schools Are Affiliated With Stanley Plotkin?

Stanley Plotkin is affiliated with the following schools:

Image Attributions

Image Source for Stanley Plotkin